Physician profile
Krishna Bhandari
NPI 1922607217
$5,790.17
in general payments reported to CMS, 2019-2025
11 companies · $1,286 in 2025
The $1,286 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $244 · 2022: $1,212 · 2023: $1,721 · 2024: $1,327 · 2025: $1,286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,309 · Travel and Lodging: $2,026.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,308.77 |
| Travel and Lodging | $2,025.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Transmedics, INC. | $2,169.22 | 2022-2024 | Organ Care System |
| Abbott Laboratories | $1,762.89 | 2023-2025 | Ensite Precision, Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Paragonix Technologies, INC. | $621.32 | 2024-2025 | Sherpapak, Liverguard, Pancreaspak |
| Medela LLC | $436.02 | 2025 | |
| Abiomed | $140.98 | 2025 | |
| Avanos Medical | $136.07 | 2021 | |
| Intuitive Surgical, INC. | $132.94 | 2024 | |
| Depuy Synthes Sales INC. | $125.00 | 2025 | Matrixrib |
| Medical Device Business Services, INC. | $107.69 | 2021 | |
| Teleflex LLC | $89.09 | 2023 | Manta |
| Genentech USA, INC. | $68.95 | 2025 | Alecensa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krishna Bhandari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.